MEANWELL CLIVE 4
4 · Fractyl Health, Inc. · Filed Feb 8, 2024
Insider Transaction Report
Form 4
MEANWELL CLIVE
Director
Transactions
- Conversion
Series F Preferred Stock
2024-02-06−596,352→ 0 total(indirect: See footnote)→ Common Stock (277,890 underlying) - Conversion
Common Stock
2024-02-06+277,890→ 277,890 total(indirect: See footnote)
Footnotes (2)
- [F1]In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock.
- [F2]Represents securities held by Population Health Capital Partners II, L.P. ("PHPII"). The Reporting Person is the Founder of Population Health Partners GP, LLC, the general partner of PHPII, and, as a result, may be deemed to share voting and investment power with respect to the shares held by PHPII. Dr. Meanwell disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.